PBAXDelisted Stock | | | USD 10.90 0.00 0.00% |
The correlation of Phoenix Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Phoenix Biotech Correlation With Market
Significant diversification
The correlation between Phoenix Biotech Acquisition and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Phoenix Biotech Acquisition and DJI in the same portfolio, assuming nothing else is changed.
Check out
Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Moving against Phoenix Stock
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations XPDBU | | TGAA | TGAA | | PLAOU | XPDBU | | PLAOU |
| | High negative correlations SCAQU | | TGAA | SCAQU | | PLAOU | SCAQU | | XPDBU |
|
Risk-Adjusted IndicatorsThere is a big difference between Phoenix Stock performing well and Phoenix Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Phoenix Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Still Interested in Phoenix Biotech Acquisition?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.